Improving the Post-transcriptional Aspects of Lentiviral Vectors
Overview
Microbiology
Authors
Affiliations
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout.
Knopp Y, Geis F, Heckl D, Horn S, Neumann T, Kuehle J Mol Ther Nucleic Acids. 2018; 13:256-274.
PMID: 30317165 PMC: 6187057. DOI: 10.1016/j.omtn.2018.09.006.
Hammerschmidt S, Werth K, Rothe M, Galla M, Permanyer M, Patzer G Front Immunol. 2018; 9:1949.
PMID: 30210501 PMC: 6120996. DOI: 10.3389/fimmu.2018.01949.
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.
Morgan R, Gray D, Lomova A, Kohn D Cell Stem Cell. 2017; 21(5):574-590.
PMID: 29100011 PMC: 6039108. DOI: 10.1016/j.stem.2017.10.010.
Pocock G, Zimdars L, Yuan M, Eliceiri K, Ahlquist P, Sherer N Mol Biol Cell. 2016; 28(3):476-487.
PMID: 27903772 PMC: 5341730. DOI: 10.1091/mbc.E16-08-0612.
Biosafety features of lentiviral vectors.
Schambach A, Zychlinski D, Ehrnstroem B, Baum C Hum Gene Ther. 2013; 24(2):132-42.
PMID: 23311447 PMC: 3581032. DOI: 10.1089/hum.2012.229.